A comprehensive view of Digestive / Gut Health. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Bioeconomy Market Intelligence Service.
FDA approves subcutaneous administration of Takeda’s ENTYVIO (vedolizumab) for maintenance therapy in moderately to severely active Crohn’s Disease
Published:
April 19, 2024
by Business Wire
|
Health Canada approves Merck & Co's KEYTRUDA in combination with chemotherapy for advanced gastric or gastroesophageal junction adenocarcinoma treatment following successful Phase 3 trial
Published:
April 19, 2024
by EquityBites
|
Cedars-Sinai study finds significant variations in small bowel microbiome between individuals of different body weights, revealing potential influences in weight gain and obesity; nearly 182 million adults in the US are overweight or have obesity
Published:
April 18, 2024
by Cedars-Sinai
|
US Patent Issued to Societe des Produits Nestle on April 16 for "Bifidobacterium longum and functional GI disorders" (Canadian, Swiss Inventors)
Published:
April 17, 2024
by U.S. Fed News
|
Colorectal cancer surgeries dropped by 17.3% in first year of COVID-19 pandemic, with more advanced stages seen in 2020 patients, according to Mayo Clinic study; African American, uninsured and Medicaid beneficiaries faced worse stages of cancer
Published:
April 12, 2024
by Physician's Briefing
|
Ask us about our Bioeconomy market view